 applic monoclon antibodi prostat biopsi fraction human prostat carcinoma feasibl monoclon antibodi prolifer marker human prostat carcinoma aspir core biopsi specimen patient prostat cancer prostat index mean cytolog smear mean frozen section histolog core biopsi signific correl percentag cell posit histolog tumor differenti patient benign prostat hyperplasia index mean mean cytolog histolog materi differ observ index benign malign prostat tissu statist clinic signific nine patient underw endocrin treatment radiotherapi followup protocol stain procedur obtain cytolog aspir biopsi month start therapi signific decreas index initi valu month prolif fraction decreas marker monoclon antibodi reliabl method prolif cell fraction human prostat cancer